No Data
No Data
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
First Subject Enrolled in Tivic Health's Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device
Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024
Tivic Health Gets Institutional Review Board's Approval for NcVNS Optimization Study
Express News | Tivic Health Receives Approval From Institutional Review Board for Ncvns Optimization Study, Readies for Enrollment
Tivic Health Has Partnered With Fletcher Spaght, To Accelerate Development Of Its Commercial Strategy For Non-Invasive Cervical Vagus Nerve Stimulation
No Data
No Data